Amedisys (AMED) Tops Q1 EPS by 12c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Amedisys Reports First Quarter 2018 Financial Results and Reaffirms 2018 Guidance
May 7, 2018 5:00 PM EDTBATON ROUGE, La., May 07, 2018 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three month period ended March 31, 2018.
Three Month Periods Ended March 31, 2018 and 2017
Net service revenue increased $34.6 million to $399.3 million compared to $364.7 million in 2017(1).Net income attributable to Amedisys, Inc. of $27.2 million compared to $15.1 million in 2017.Net income attributable to Amedisys, Inc. per diluted share of $0.79 compared to $0.44 in 2017.Adjusted Quarterly Results*
Adjusted EBITDA of $41.7 million compared to $32.0 million in 2017.Adjusted net income attributable to Amedisys, Inc. of $27.3 million... More